Stay updated on BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer

Sign up to get notified when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.
Latest website image capture
Clouds background image

Latest updates to the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page

  1. Check
    yesterday
    Change Detected
    Summary
    The webpage has been updated to include new drug information for Nivolumab and Pazopanib, as well as additional details about clear-cell metastatic renal cell carcinoma. However, several previous entries related to drug classifications and genetic resources have been removed.
    Difference
    5%
    Check dated 2025-08-30T11:49:39.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-16T04:38:01.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.0%
    Check dated 2025-08-08T23:54:18.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.5%
    Check dated 2025-08-01T19:25:21.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.
    Difference
    0.1%
    Check dated 2025-07-25T14:53:57.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.0%
    Check dated 2025-07-18T11:45:46.000Z thumbnail image

Stay in the know with updates to BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer

Enter your email address, and we'll notify you when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.